Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Pub
Cannabis Significantly Improves Symptoms For Most Cancer Survivors, Confirms New Study
A newly published study in the Journal of Cancer Survivorship has shown the prevalence and motivations behind cannabis use among individuals who have battled cancer.
Cell Therapy Focused Allogene Therapeutics’ Resource Prioritization A Bold Move, Says Analyst
Allogene Therapeutics Inc (NASDAQ: ALLO) announced deprioritizing the currently enrolling third line Phase 2 ALPHA2 and EXPAND trials of cema-cel (ALLO-501A) and is now pursuing a potentially pivotal trial (ALPHA3) evaluating cema-cel as a consolidation therapy in large B-cell lymphoma (LBCL) patients
Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday.
The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P 500 also rose, gaining, 0.26% to 4,701.05.
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of Applied Therapeutics, Inc.
Why Castor Maritime Shares Are Gaining Friday
Castor Maritime Inc. (NASDAQ: CTRM) on Friday said it inked a pact to sell M/V Magic Venus, a 2010-built Kamsarmax bulk carrier vessel,
Dow Turns Lower; ISM Services PMI Falls In December
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday.
The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P 500 also rose, gaining, 0.12% to 4,694.09.
What’s Going On With Immunic Stock?
Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.
What’s Going On With Verb Technology Stock?
Verb Technology Company Inc (NASDAQ: VERB) shares are trading lower by 18% to $0.13 Friday morning after the company recently concluded a $3 million preferred stock financing for its MARKET.live
Why Sana Biotechnology Shares Are Rising Today
Sana Biotechnology, Inc. (NASDAQ: SANA) announced the U.S.